HomeSONN • NASDAQ
Follow
Sonnet BioTherapeutics Holdings, Inc.
Previous close
$1.97
Day range
$1.80 - $1.97
Year range
$1.08 - $26.37
Market cap
5.71M USD
Avg Volume
188.14K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 18.63K | -50.00% |
Operating expense | 653.46K | -65.67% |
Net income | -1.17M | 78.92% |
Net profit margin | -6.27K | 57.83% |
Earnings per share | -0.31 | 98.24% |
EBITDA | -1.28M | 77.26% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 3.02M | 77.67% |
Total assets | 5.34M | 7.99% |
Total liabilities | 2.77M | -67.39% |
Total equity | 2.57M | — |
Shares outstanding | 3.07M | — |
Price to book | 2.35 | — |
Return on assets | -59.39% | — |
Return on capital | -233.62% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -1.17M | 78.92% |
Cash from operations | -3.09M | 47.73% |
Cash from investing | — | — |
Cash from financing | 3.84M | -15.87% |
Net change in cash | 747.13K | 155.25% |
Free cash flow | -2.74M | 27.98% |
About
Founded
1999
Headquarters
Website
Employees
12